contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
      researchContentUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


getinge-twenty-years-of-driving-the-future-of-surgery

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Getinge is a Swedish global medical technology company specializing in providing equipment and IT systems to the healthcare and life science industries. The company offers solutions for operating rooms, intensive care units, sterilization centers, and drug development, among other things. The company was founded in 1904 and is headquartered in Gothenburg.

Getinge

[image]"Back in 1999 when we started providing these solutions, it was actually a customer who came to us because we had the heart of the Hybrid OR - the operating table," recalls Thomas Schneider...

[image]"Back in 1999 when we started providing these solutions, it was actually a customer who came to us because we had the heart of the Hybrid OR - the operating table," recalls Thomas Schneider, Vice President Global Product Management at Getinge.The main request from the customer was clear - they needed more and better real time information during surgery, especially about what was going on inside the patient. And they needed this information without being forced to lift or move the patient.Getinge teamed up with world-leading imaging partners to provide a complete solution and the best possible working environment for clinicians, where they could diagnose and treat patients at the very same time."During the years we come to have much more to offer for the Hybrid OR - such as modular room systems, OR integration systems, surgical lights, pendants, anesthesia machines and mechanical ventilators. The Hybrid OR really is the complete solution," says Thomas Schneider.Hybrid ORs enables numerous interdisciplinary use as well as conventional procedures, in a highly cost-efficient and flexible way."Key is to optimize the use of space and equipment to maximize OR uptime and the use of expensive equipment such as imaging technology which can also be used for non-operative diagnostic procedures," explains Klaus Christian who has been heading the Hybrid OR team at Getinge for the last ten years.At the same time, trauma patient outcomes are significantly improved in the Hybrid OR since it reduces transport between departments and medical teams. As the patient remains in the sterile OR the risk of health care acquired infections is reduced. Also, repeated surgeries can be avoided since the clinicians immediately see if the ongoing surgery is successful, which means reducing the amount of anesthetic needed."It is simply a safe area where you have everything you need to care for the patient in the best possible way. The imaging systems makes the invisible visible and the medical team can continue with procedures without putting the patient at risk by moving him or her," says Klaus.Patients who are scheduled for routine procedures also benefit from treatment in a Hybrid OR."Clear intraoperative tumor visualization, for example, can improve tumor resection, minimize damage to healthy tissue and deliver better patient outcomes," explains Thomas Reichenbach, Senior Product Support Manager Hybrid OR Solutions at Getinge.He continues:"Even if we celebrate twenty years of providing this solution we still consider it the future of surgery; it is truly an environment with increasing possibilities. With over 1350 Hybrid ORs sold worldwide we have gained deep experience and still see huge potential to create even more value in the Hybrid OR together with our imaging partners and customers. It is an ongoing exciting journey where we will continue to be a pioneer."Find out more about Getinge's solutions for the Hybrid OR (<a href="https://www.getinge.com/int/solutions/hospital-departments/hybrid-or/">https://www.getinge.com/int/solutions/hospital-departments/hybrid-or/</a>)Media contact:Anna Appelqvist, Vice President Corporate Communications Phone: +46 (0)10 335 5906 E-mail: <virtloc>anna.appelqvist@getinge.com</virtloc>

Getinge: Twenty years of driving the future of surgery

Financial Key Ratios: EV/EBIT, EV/EBITA, EV/EBITDA, and EV/Sales

Faron Pharmaceuticals

Herantis Pharma

Mendus

Probabilities of success in drug development

Nordea Bank

Nordea shareholder? It’s easier than ever to attend the AGM with a new digital set-up

Return on capital (ROE, ROI, ROIC, RONIC)

The DuPont formula helps understand the dynamics of value creation